Beranda › Kanker Payudara › Connecticut › Bridgeport
Uji klinis Kanker Payudara di Bridgeport, CT
21 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Bridgeport (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Stony Brook University Medical Center, Stony Brook · 18 mi jauhnya
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Menerima pesertaFase 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · 18 mi jauhnya
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Menerima pesertaFase 3
- Research Site, Stony Brook · 18 mi jauhnya
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Menerima pesertaFase 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 4 mi jauhnya
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · 5 mi jauhnya
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Menerima peserta
- Stony Brook Cancer Center, Stony Brook · 18 mi jauhnya
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Menerima pesertaFase 1/2
- Stony Brook University Hospital, Stony Brook · 18 mi jauhnya
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Menerima pesertaFase 3
- Stony Brook University Medical Center, Stony Brook · 18 mi jauhnya
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Menerima pesertaFase 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi jauhnya
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Menerima pesertaFase 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · 19 mi jauhnya
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · 19 mi jauhnya
- New York Cancers & Blood Specialists, Port Jefferson Station · 19 mi jauhnya
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi jauhnya
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi jauhnya
- dan 1 lainnya
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Menerima pesertaFase 2
- Stony Brook Cancer Center, Stony Brook · 18 mi jauhnya
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Menerima pesertaFase 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · 4 mi jauhnya
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · 5 mi jauhnya
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Menerima pesertaFase 1
- New York Cancer and Blood Specialists, Port Jefferson Station · 19 mi jauhnya
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Menerima pesertaFase 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi jauhnya
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Menerima pesertaFase 3
- Smilow Cancer Hospital - Fairfield, Fairfield · 5 mi jauhnya
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Menerima pesertaFase 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi jauhnya
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi jauhnya
- Stony Brook University Medical Center, Stony Brook · 18 mi jauhnya
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Menerima pesertaStudi observasional
- Stony Brook Medicine, Stony Brook · 18 mi jauhnya
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
Menerima pesertaFase awal 1
- Stony Brook Breast Center, Stony Brook · 18 mi jauhnya
Definitive Radiation Therapy for Inoperable Breast Cancer
Menerima peserta
- Stony Brook University Cancer Center, Stony Brook · 18 mi jauhnya
Definitive Radiation for High-Risk Spine Metastases
Menerima pesertaFase 2
- Stony Brook University Hospital, Stony Brook · 18 mi jauhnya
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Menerima pesertaStudi observasional
- Stony Brook University Cancer Center, Stony Brook · 18 mi jauhnya
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Bridgeport
- Kanker Paru Non-Sel Kecil14 studi
- Kanker Paru13 studi
- Leukemia Mieloid Akut12 studi
- Penyakit Kardiovaskular9 studi
- Kanker (semua jenis)8 studi
- Karsinoma Sel Skuamosa Kepala dan Leher8 studi
- Kanker Metastatik7 studi
- Gagal Jantung7 studi
- Aneurisma Otak6 studi
- Mieloma Multipel6 studi
- Kanker Prostat6 studi
- Kanker Ovarium5 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.